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The coagulation pathways not only serve hemostatic functions but also appear to 
be important participants in inflammatory responses, including certain immunologi- 
cally induced tissue lesions.  Local deposition of fibrin is characteristically an early 
and active process in the immunologic lesions of experimental allergic encephalomy- 
elitis (1, 2), acute proliferative glomerulonephritis (3), delayed cutaneous hypersensi- 
tivity (4, 5), and the rheumatoid synovium (6).  As one possible mechanism  for this 
phenomenon, it has been observed that  human  lymphoid cells respond in  vitro to 
diverse immunologic stimuli by generation of cellular procoagulant activity (PCA), 1 
an effector limb culminating in the generation of fibrin. Whereas C5a (7), lectins (8), 
bacterial  lipopolysaccharide (LPS)  (9), and  allogeneic cells  (10)  have all  been  de- 
scribed to induce a  procoagulant response in  vitro, only more recently has  it been 
suggested that immune complexes also possess this potential (8,  11). Rothberger et al. 
(1 1)  observed  a  small  but  significant  PCA  response  of human  peripheral  blood 
mononuclear cells to aggregated IgG or soluble immune complexes in antigen excess. 
Prydz et al.  (8)  have suggested that  immune complexes may directly stimulate  the 
monocyte to produce PCA. 
Studies of LPS-induced PCA have provided evidence that the human monocyte is 
the source of PCA  (12,  13). It has also been established that in murine splenic cells 
stimulated  by LPS,  the  macrophage contains  the  PCA  product  (14).  In  addition, 
lymphocyte collaboration was  strictly required for the  induction  of splenic  macro- 
phage  PCA.  We  have  recently suggested  in  a  preliminary  report  (15)  that  PCA 
generated by human peripheral blood mononuclear cells (PBM) can be localized to 
the monocyte and requires lymphocyte collaboration. Edwards and Rickles (12) have 
presented  evidence  for  a  lymphokine-mediated  mechanism  in  generating  a  PCA 
response  to  LPS and  lectin,  and  have suggested  that  the  lymphocyte may play a 
facilitating but not a requisite role. In contrast, Prydz et al.  (13) suggest that human 
monocytes are autonomous in the procoagulant response to various stimuli. 
In the present study, we investigate the cellular pathways by which soluble immune 
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complexes  or  aggregated  IgG  induce  PCA  response  in  human  PBM  and  provide 
evidence that lymphocyte collaboration is required for the immune complex-induced 
production of PCA by monocytes. 
Materials  and Methods 
Cell Isolation and Culture.  PBM were isolated from heparinized venous blood, diluted twofold 
in RPMI  1640 (Flow Laboratories, Inc., Rockville, Md.)  containing  100 U/ml penicillin,  50 
#g/ml streptomycin, and 2 mM L-glutamine/ml (Grand Island Biological Co., Grand Island, 
N. Y.)  (incomplete medium), and centrifugated over Ficoil (Sigma Chemical Co., St.  Louis, 
Mo.) -Hypaque (Winthrop Laboratories, New York) (density 1.074 g/ml) at 1,400g for 10 rain. 
The interface cells, cytologically 98% mononuclear, were washed twice in incomplete medium 
and resuspended in RPMI 1640 containing 10% heat-inactivated fetal calf serum (Grand Island 
Biological Co., Grand Island, N.  Y.)  (complete medium).  More than  98%  of the cells  were 
viable  as  assessed  by  trypan  blue  exclusion;  <0.2%  of the  cells  were  polymorphonuclear 
leukocytes. 
Adherent cells  (monocytes) were isolated by incubating PBM at  1 ×  106/ml in complete 
medium in 16-mm plastic tissue culture plates (24; Costar, Data Packaging, Cambridge, Mass.) 
at  37°C  and  6%  CO2  for  72-96  h.  Cells  were  fed  at  72  h  with  fresh  complete  medium. 
Nonadherent cells  (lymphoeytes) were removed by vigorously washing with medium and the 
adherent cells (monocytes) were detached by incubation at 22°C for 45 min in Puck's Saline A 
containing 3 mM EDTA and 3% (wt:vol) bovine serum albumin on a gyrotory platform at 150 
cycles/min. Lymphocyte recovery was 72  +  5% and  monocyte recovery was 65  +  4%. The 
lymphocytes contained <2% esterase-positive  cells,  whereas  the monocytes contained >98% 
esterase-positive  cells.  Nonspecific esterase,  a  marker  for monocytes and  macrophages,  was 
assayed according to Li et al.  (16). 
Platelet-poor mononuclear cells were prepared by first centrifuging whole blood at  120 g for 
15  min  and  removing  the  platelet-rich  plasma  before  isolating  PBM  by  Ficoll-Hypaque 
centrifugation. PBM thus prepared contained <1 platelet  per mononuclear cell, as compared 
with 35-40 platelets per PBM when prepared in the conventional manner. 
Platelets  were  isolated  from  blood  drawn  into  acid  citrate  dextrose  anticoagulant.  The 
platelet-rich plasma was obtained by centrifuging the blood at  120 g for 15 rain. The platelets 
were either washed twice by centrifuging the platelet-rich plasma at  1,200 g for 15 min, and 
resuspended in incomplete medium, or alternatively, the platelet-rich plasma was passed over 
a Sepharose CL-2B gel filtration column and the platelets were recovered in the void volume. 
All platelet preparations contained <1 mononuclear cell per l0  s platelets. 
Lymphocyte-conditioned medium was obtained by incubating lymphocytes with antigen: 
antibody (Ag:Ab) at  37°C for 1 h, washing the cells twice, and resuspending them in fresh 
medium for an additional  6 h at  37°C. This second medium was then used as lymphocyte- 
conditioned medium. Cells were incubated at indicated concentrations at 37°C, 6% CO2 in 16- 
mm dishes,  or 12- ×  75-mm polypropylene tubes (Falcon Labware, Div. of Becton, Dickinson 
& Co., Oxnard, Calif.)  in the presence or absence of designated stimuli. All additions to cells 
were sterilized  by filtration  through 0.22-/tin  filters  (Millipore  Corp., Bedford, Mass.)  or by 
ultraviolet radiation, and assayed for freedom from LPS by amebocyte lysate assay (E-toxate; 
Sigma Chemical Co.) and by heat inactivation. 
Proteins.  The IgG fraction of goat anti-human serum albumin, adsorbed three times with 
human  Cohn  fraction  III and  clarified,  was  isolated  by  precipitation  three  times  at  50% 
ammonium sulfate saturation, followed by ion-exchange chromatography on DEAE-cellulose 
(DE-52; Whatman, Inc., Kent, England) in 0.02 M sodium phosphate, pH 7.2, and molecular 
sieve chromatography on Sephacryl S-200 (Pharmacia Fine Chemicals, Piscataway, N. J.)  in 
the same phosphate buffer. 
The IgG antibody was immunochemically purified from the IgG fraction of the antisera by 
affinity chromatography on human serum albumin (HSA) (Calbiochem-Behring Corp., Amer- 
ican Hoechst Corp., San Diego, Calif.)  conjugated to cyanogen bromide-activated Sepharose 
4B (Pharmacia Fine Chemicals). Antibody was eluted at 4°C with 1.0 M glycine-HC1, pH 2.8. 
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7.2. The antibody produced a  single precipitin line by double diffusion analysis in gel with 
rabbit anti-goat whole serum (Bio-Rad Laboratories, Richmond, Calif.) and produced a single 
preeipitin against human serum. Glycine was removed by dialysis before experimental use. 
Anti-HSA:HSA complexes in slight antigen excess were formed by adding purified antibody 
(3.7 mg/ml) to an equal volume of doubling dilutions of HSA from 25.6 to 0.2 mg/ml. After 
a  1-h incubation at 22°C, precipitation was read visually. A concentration of HSA twice as 
high as that producing precipitation, usually 1.6 mg HSA per mg antibody (molar ratio: 3.5:1, 
Ag:Ab), was judged to be in antigen excess, and was used for incubation with cells. Concentra- 
tion of Ag:Ab complexes is expressed  on the basis of IgG content. To prepare aggregated IgG, 
the IgG fraction from nonimmune  goat serum at 7.5 mg/ml was incubated at 63°C for 30 rain, 
then  centrifuged at  3,000  g  for  30  min  and  the  soluble aggre~,~tes  were  used.  The  IgG 
concentration was determined from absorbance at 280 nm usingEzs0  =  14.3. 
Bacterial LPS and Assay.  LPS  was  isolated from  Escherichia coli 0111:B4 by the  butanol 
method and was kindly provided by Dr. David Morrison (Emory University, Atlanta, Ga.). 
The potential for contamination  of stimulatory proteins by endotoxin was monitored by a heat- 
inactivation assay as previously described (17). Heating-aggregated IgG or Ag:Ab solutions to 
99°C for 30 rain resulted in denaturation and precipitation of the antibody proteins, although 
endotoxin was not destroyed (18). As such, Ag:Ab or aggregated Ig'G heated to 99°C for 30 rain 
and added to PBM for 6 h were unable to induce increased PCA from PBM; however, added 
endotoxin (E.  coli 0111:B4)  retained the  ability to  induce increased PCA  from  PBM.  All 
stimulatory proteins and media were found to contain <2 ng LPS per mg of antibody protein. 
PCA Assay.  Samples were assayed for PCA by reference to their ability to accelerate the 
spontaneous clotting of recalcified normal human citrated platelet-poor plasma in a one-stage 
clotting assay (14, 17). The assay  consisted of 0.1  ml of sample added to 0.1  ml of normal 
citrated human plasma in a  12- ×  75-mm glass tube, after which 0.1 ml of 0.025 M CaCI2 was 
added to start the reaction. The time(s) to form a visible clot with constant rocking at 37°C was 
observed and converted to milliunits of PCA by reference to a standard curve derived from 
rabbit brain thromboplastin standard (Dade Div., American Hospital Supply Corp., Miami, 
Fla.) at 36 mg dry mass/ml, which was assigned a value of 100,000 mU. 10-fold serial dilutions 
were used to produce a standard log-log plot, which was linear from 1 to  I0,000  mU and had 
a precision of 7.6% (coefficient of variation). To assay the expression of PCA on viable cells, 0.1 
ml washed cells suspended in RPMI 1640 were assayed. To determine the total content of PCA 
within, the cells, the washed cells in 0.5 ml of RPMI 1640 were first subjected to three cycles of 
freeze-thawing at  -70  °  and  37°C,  followed  by  sonication  (model  A-140  sonicator;  Heat 
Systems-Ultrasonics, Inc., Plainview, N. Y.) with two  10-s bursts at setting 3 with ice cooling, 
and assayed as above. Identification  of the type of PCA was done by assay in known coagulation 
factor-deficient plasmas (George King, Overland Park, Kans.) and RPMI 1640 alone, with or 
without Ag:Ab or aggregated IgG, were devoid of PCA  (0.6 mU PCA/ml containing 1 mg 
IgG). Data are presented as mean + standard deviation. Stimulation with Ag:Ab or aggregated 
IgG yielded almost identical cellular PCA values. As such, the data have been combined. 
PCA Plaque Assay.  For direct cytologic localization of PCA to individual viable cells, cell 
suspensions were incubated on glass microscope slides at 37°C for 2 h in complete medium in 
6% CO2. The medium was carefully removed without displacing the cells, and the cells were 
overlaid with plasma-agarose prepared  from three volumes of 2% agarose  (Indubiose A-37; 
L'Industire  Biologique,  Francaise,  S.A.)  in  Hepes-buffered  minimum  essential  medium, 
(HMEM)  (Flow Laboratories) containing 3.67  g% CaC1, and  1 vol of platelet-poor citrated 
normal human plasma, which was added to the agarose at 38-39°C. This mixture (1.0-1.5 ml) 
was immediately poured on the slide to overlay the cells and allowed to gel at 37°C during a 
10-rain reaction interval. The reaction was  terminated by placing the slides in cold HMEM 
containing 10 U  heparin/ml and washed for  16-20 h. The slides were fixed  and stained for 
nonspecific esterase  and counterstained with methyl green. Alternatively, other stains such as 
Giemsa have been used.  For assays of total cellular PCA content, the cells were  centrifuged 
onto the slides  in a cytocentrifuge, fixed  for 45 s in acetone, and dried. The agarose-plasma 
overlay was  applied as  described above and after the coagulation reaction was  stained for 
nonspecific esterase. The presence of PCA was clearly indicated by the formation of pericellular 
strands of fibrin, which contrasted with the red cytoplasmic reaction for nonspecific esterase. BRADFORD  S.  SCHWARTZ  AND  THOMAS  S.  EDGINGTON  895 
Results 
Freshly isolated  human  PBM  contain  and  express low  levels of PCA;  however, 
basal activity increases in vitro to a relatively constant control concentration within 
4-6 h  in the absence of known exogenous stimuli  and  in the absence of detectable 
LPS.  The PCA on the surface of viable cells approximated 20% of the total  PCA 
content of disrupted ceils (Table I). PBM were separated by adherence for 72 h  into 
lymphocytes and  monocytes, and  each fraction contained <1-2%  of the other cell 
class by reference to diffuse cytoplasmic nonspecific esterase. From 90 to 93% of the 
PCA  associated  with  the  unfractionated  PBM  was  recovered  with  the  isolated 
monocytes (Table I). When soluble Ag:Ab complexes or aggregated IgG were added 
to isolated lymphocytes or monocytes there was no increase in PCA. However, when 
either stimulus was added to PBM, a 5-fold increase in total PCA content and a 3.8- 
fold increase in viable expression of PCA as compared with control incubated cells 
was observed (Table I; Fig.  1). This represented a  30-fold and 22.8-fold higher PCA, 
respectively, than the basal activity of freshly isolated PBM not subjected to in vitro 
cultivation. 
Kinetics of PCA Induction by Ag:Ab Complexes and Aggregated lgG.  Incubation of PBM 
with either Ag:Ab complexes or aggregated IgG at an arbitrarily selected dose of 90 
#g/ml  induced progressive increases in cellular PCA over identical time-courses. A 
representative set  of experiments  is  shown  in  Fig.  1.  A  slight  increase  in  PCA  of 
stimulated vs. control ceils was evident by  1 h. At 4  h, the PCA response was  half 
maximal, and became maximal at 6 h  with only a  slight decay of activity over the 
next 30 h. Cells incubated in the absence of Ag:Ab (control cultures) exhibit a slight 
increase in  PCA with time. The time-course of this increase paralleled the Ag:Ab- 
induced PCA increase; however, the magnitude of the spontaneous increase in the 
control cultures was much less. 
Dose-Dependence of PCA Response.  To identify the threshold for stimulation of PCA 
and to determine whether there is a dose-dependent effect of the stimulus, increasing 
TABLE I 
PCA of Human Lymphocytes and Monocytes  from Control Culture and after Ag.'Ab 
Exposure 
Ag:Ab  Intact viable cells  Cell homogenates 
Peripheral blood  or ag- 
mU  cell population*  gregated  Clotting  PCA/10  s  Clotting  mU PCA/ 
IgG ~g/  time  time  10  6 cells 
ml  Cells 
$  $ 
PBM  0  63 ±  6  85 ±  11  40 :t: 3  495 3= 26 
PBM  90  44 ±  4  327 ±  20  28:1:1  2,040:1:100 
Lymphocytes~c  0  89 ±  11  22 :l: 2  66:1:5  72 ±  14 
Lymphocytes  90  92 ±  13  19 ±  3  65 :t: 3  72 ±  9 
Monocytes§  0  37:1:2  565 ±  41  25 ±  2  3,180 ±  288 
Monocytes  90  39 ±  3  520 ±  36  25 ±  1  3,200 ±  172 
* Cells incubated with or without Ag:Ab or  aggregated IgG  for 6  h, washed, and 
assayed for viable expression of PCA; or subjected to freeze-thaw and sonication as 
in Materials and Methods, and assayed for total cellular content of PCA. 
:~ >98% esterase negative. 
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FIG.  1.  Induction of PCA in human PBM by Ag:Ab complexes or aggregated IgG. 1 x  108 PBM/ 
ml were incubated in the presence (0) or absence (A) of 90 ~g/ml of Ag:Ah of aggregated IgG at 
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Fio.  2.  Induction of cellular PCA by various concentrations of Ag:Ab complexes. 1 ×  106 PBM in 
l  ml were incubated for 6 h at 37°C with increasing concentrations of Ag:Ab and assayed for total 
cellular content of PCA. 
concentrations of Ag:Ab were incubated with  1 ×  106 PBM for 6 h and the cells were 
assayed for total cellular PCA. There was a  1.5-fold increase over 6 h in control PCA 
induced by 10/tg Ag:Ab, and a maximal response was obtained with 75 #g/ml, which 
was relatively constant at higher doses (Fig.  2). 
Cellular Origin of Induced PCA.  The cellular source of the PCA induced in the PBM 
preparation was directly examined. PBM were incubated with aggregated IgG or Ag: 
Ab complexes during the final  12  h  of separation by adherence.  Lymphocytes and 
monocytes were then separated and each cell fraction was assayed for total cellular 
PCA. Lymphocytes showed virtually no increase in PCA (Table II), whereas mono- 
cytes from stimulated cultures contained fivefold more PCA than ceils  from control 
cultures. Cell death did not account for this difference, as lymphocyte and monocyte 
viability were virtually identical.  Summation of PCA from lymphocytes and mono- 
cytes accounted for  112% of the total  PCA of whole PBM in  control cultures,  and 
119% of that present in Ag:Ab-stimulated cultures. 
To confirm that  the monocyte was the cellular source of the PCA, rather than a 
minor  population  of cells,  a  cytologic  assay  was  used  to  directly  visualize  cells 
expressing PCA. Cells (stimulated or control) were incubated on a glass slide to which 
agarose containing plasma and calcium was carefully overlaid. After a  brief incuba- 
tion,  the  formation  of  fibrin  around  individual  cells  could  be  observed.  These 
preparations were stained for nonspecific esterase as a reliable marker for monocytes 
(21). Cell types and the presence or absence of pericellutar fibrin as an index of PCA BRADFORD S.  SCHWARTZ  AND THOMAS  S.  EDGINGTON 
TABLE II 
PCA of Cell Populations Isolated  from Human PBM after Stimulation with 
Ag:Ab or Aggregated lgG 
PCA (mU/106 cells)  Stimu- 
Cell population*  lated/con- 
Control  Ag:Ab  or ag-  trol 
gregated IGg~: 
Whole mononuclear  455 + 22  2,050 :t: 1,200  4.7 
Lymphocytes  72 +  11  80:1:4  1.1 
Monocytes  3,100 + 240  16,875  +  1,430  5.2 
* Cells incubated at  I ×  106/ml with or without Ag:Ab or aggregated IgG, 
separated by adherence into lymphocytes and monocytes, then assayed for 
total cellular content of PCA. 
9o ~g/ml. 
897 
FIe. 3.  Cytologic assay for cell type and fibrin deposition among control-incubated and Ag:Ab- 
incubated cells. Cells were overlaid at  37°C with plasma-CaCl2 containing agarose to allow for 
fibrin formation, then stained for cellular identification via nonspecific  esterase as in Materials and 
Methods. (A)  Esterase-positive  cell (monocyte) from control-incubated culture shows no fibrin 
present. (B) Esterase-positive  cell (monocyte) from Ag:Ab-exposed  culture with easily identifiable 
pericellular fibrin formation. 
were directly assessed. Upon analysis of cells in unstimulated 6-h control cultures (Fig. 
3A), only 2% of lymphocytes had pericellular deposits of fibrin, whereas  15% of the 
monocytes were positive for PCA (Table III). In a  similar analysis of PBM that had 
been incubated with Ag:Ab or aggregated IgG, 9% of lymphocytelike cells (negative 
for nonspecific esterase) were PCA positive and 91% of the monocytes were surrounded 
by fibrin (Fig. 3; Table III). Thus, PCA was predominantly associated with most cells 
identified as monocytes by simultaneous nonspecific esterase staining and cytology, 
and was not associated with a minor cell population. The identity of the PCA-positive 
lymphocytelike cells remains to be resolved. 
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TABLE III 
Cells Positive  for Fibrin Deposition by Cytologic Analysis 
Cell population* 
Percent of cells positive for fibrin 
deposition:[: 
Basal  Ag:Ab, 90 btg/ml 
Lymphocytes 
Viable  2  9 
Fixed  4  13 
Monocytes 
Viable  15  91 
Fixed  21  100 
* Cells incubated with or without  Ag:Ab for 6 h, washed, and assayed by 
cytologic assay in either viable or fixed state as in Materials and Methods. 
Mean of 300 cells. 
TASLE IV 
Cell Populations Required  for Amplification of Human Monocyte PCA 
Ag:Ab 
or ag- 
Stimulatedcel[.  gregated  Collaboratingcell  Time  PCA,cellsmU/106 
IgG, ~g/ 
l0  s cells 
$ 
Lymphocyte~  0  Monocyte  38.2 :t: 0.9  600 + 40 
Lymphocyte  1130  Monocyte  27.3 + 0.7  2,415 +  115 
Monocyte§  0  Lymphocyte  37.6:1:1.6  620 :t: 60 
Monocyte  100  Lymphocyte  37.7 :t: 1.l  625 :t: 25 
* I X 106 stimulated cells incubated with Ag:Ab (100/tg/mt)  or sterile saline 
for 6 h, washed, and added to collaborative cells at a lymphocyte to monocyte 
ratio of 6: l. 
~: >98% nonspecific esterase negative. 
§ >98% nonspecific esterase positive. 
seen when PBM, as opposed to lymphocytes or monocytes alone, were incubated with 
Ag:Ab complexes or aggregated IgG, additional experiments were performed to define 
the  collaborative requirements  for  induction  of monocyte  PCA.  Lymphocytes  and 
monocytes  mixed  in  physiologic  proportion  (6:1  lymphocytes:monocytes)  in  the 
presence of Ag:Ab complexes or aggregated IgG responded with a  3.6-fold increase in 
PCA over control cultures (~20-fold over basal 0-h cells). Similarly, lymphocytes that 
had been incubated with Ag:Ab or aggregated IgG for 6  h, thoroughly washed, and 
added to monocytes, mediated a  3.7-fold increase in the PCA content of the reisolated 
monocytes.  Incubation  of monocytes  with  Ag:Ab or  aggregated  IgG,  followed  by 
washing  and  the  addition  of  unstimulated  lymphocytes,  did  not  result  in  PCA 
induction (Table IV) nor did incubation of monocytes with these stimuli alone (Table 
I).  Indeed,  lymphocytes  incubated  with  Ag:Ab  or  aggregated  IgG  appeared  to 
represent the sole requirement  for induction of an  increase in monocyte PCA. This 
increase in PCA was observed even when non-cell-associated Ag:Ab was removed by 
washing the lymphocytes before they were added to monocytes. Similarly, erythrocytes 
incubated with Ag:Ab did not induce increased PCA when added to monocytes (data 
not shown). 
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of lymphocytes that  had been incubated with Ag:Ab were washed and  added to a 
constant number of monocytes (1  ×  105 per 16-mm well in  1 ml) and the generation 
of PCA was monitored (Fig. 4). At ratios of one stimulated lymphocyte per monocyte, 
no increase in PCA as compared with control cells was observed. The increase of PCA 
was first observed at two Ag:Ab-stimulated lymphocytes per monocyte and this was 
maximal at 4:1. 
Because standard preparations of PBM contained 35-40 platelets per mononuclear 
cell, the possible participation of platelets in PCA production was examined. PBM 
containing 0.2-0.5 platelet per PBM were prepared, and separated into lymphocyte 
and  monocyte fractions.  Platelet-poor lymphocytes (<0.5  platelet  per lymphocyte) 
when  incubated  with  Ag:Ab  complexes,  induced  levels  of PCA  in  platelet-poor 
monocytes to which they were added (Table V) identical to conventional preparations 
of lymphocytes and  monocytes. The presence of platelets  in  the mononuclear cell 
cultures did not demonstrably enhance or suppress  the PCA response.  In addition, 
30- 
0-  X 
~=  20- 
I=  C 
==  O  -  ~=  10 
=  T  I  =  T 
X  r  I  x  X 
tymphocyte:Monocyte Ratio 
Fro.  4.  Lymphocyte  collaboration  is  required  for  generation  of monocyte  PCA.  PBM  were 
separated by adherence into lymphocyte- and monocyte-enriched fractions, each containing <2% of 
the other cell type. Lymphocytes (1 X  106/ml) were incubated with 100 btg/ml Ag:Ab complexes or 
aggregated IgG for 6 h at 37°C, washed twice, and resuspended at various concentrations. Increasing 
numbers of triggered lymphocytes were then added to 1 X  105 monocytes in a final volume of 1 ml 
for a further 6 h at 37°C, at which time the cells were assayed for total content of PCA. 
TABLE  V 
Platelets Do Not Substitute  for Lymphocytes in Ag:Ab-induced PCA in Human 
PBM 
Cell population added to  Ag:Ab  mU total content PCA, 
monocytes*  l0  e monocytes 
Itg/ml 
None  0  3,450 ±  420 
None  100  3,600 ±  270 
Lymphocyte$  0  3,200 ±  300 
Lymphocyte  100  17,400:1:1,450 
Lymphocyte plus platelets  0  3,600 :t: 400 
Lymphocyte plus platelets  I00  16,900  ±  1,600 
Platelets§  0  3,300 ±  190 
Platelets  100  3.400 ±  260 
* Cell population incubated with 100 #g/ml Ag:Ab, or sterile saline for 6 h at 
37°C,  6%  CO2,  washed,  and added  to  105  monocytes for  a  further 6  h 
incubation. The monocytes were assayed for total cellular PCA. 
$ 7 X  105 lymphocytes containing <0.4 platelet/lymphocyte. 
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TABLE  VI 
Intact Viable Lymphocytes Are Required  for Mediation of Ag:Ab or Aggregated 
IgG-induced Monocyte PCA 
Ag:Ab or  PCA, (mU/lO  6 
Monocyte cultured with*  aggregated 
IgG  monocytes) 
t~g/ml 
Lymphocytes$  0  3,200 ± 200 
Lymphocytes  100  17,400 ±  1,620 
Lymphocyte supernate§  0  3,450 ±  180 
Lymphocyte supernate  100  3,600 ± 210 
Lymphocyte-conditioned  medial]  0  3,320 +  120 
Lymphocyte-conditioned  media  100  3,500 ± 200 
Disrupted lymphocyte's¶  0  3,100 ± 240 
Disrupted lymphocytes  100  3,250 ±  110 
* 1 ×  105 monocytes  cultured as indicated. After 6 h, the reisolated monocytes 
were assayed for their total cell content PCA. 
:1:1 ×  106 lymphocytes  cultured at 370C in presence or absence of Ag:Ab for 
6 h, washed, and added to 105 monocytes. 
§ 1 X 106 lymphocytes cultured at 37°C in presence or absence of Ag:Ab for 
6 h, medium removed and added to 10  ~  monocytes. 
]1 1 ×  106 lymphocytes cultured at 37°C in presence or absence of Ag:Ab for 
6 h, washed, and incubated for an additional 6 h in fresh culture medium. 
This second culture medium was removed and added to 105 monoeytes. 
¶ Lymphocytes  cultured at 37°C in the presence or absence of Ag:Ab for 6 h, 
washed, subjected to three cycles  of freeze-thaw as in Materials and Methods, 
and added to the monocytes. 
platelets that had been isolated by washing or gel filtration and incubated with Ag: 
Ab complexes or aggregated IgG did not induce monocyte PCA. Also, such platelets 
did not modify the observed PCA of monocytes to which they were added (Table V). 
It  should  be  noted  that  the  platelets  were  removed  from  adherent  monocytes by 
washing before  the  assay of PCA  to  avoid the  direct  contribution of any PCA of 
platelets per se. 
Nature of Lymphocyte Collaboration.  To investigate the lymphocyte requirement and 
determine whether lymphocytes per se  were  required to  induce monocyte PCA or 
whether monocyte induction could be mediated by a soluble product, lymphocytes at 
106/ml  were  cultured  in  the  presence  of  100  /~g  of soluble  Ag:Ab  for  6  h.  The 
supernatant medium was added directly to 105 monocytes, incubation was continued 
for  6  h,  and  the  monocytes  were  assayed  for  total  cellular  PCA.  Alternatively, 
lymphocyte-conditioned  medium or lymphocyte homogenate was added to monocyte 
cultures for  6  h,  and the  total  monocyte PCA was  determined. Only when  intact 
viable lymphocytes, which had been incubated with Ag:Ab complexes, were added to 
monocytes was there  induction of monocyte PCA.  Neither addition of supernatant 
medium  from  the  lymphocyte cultures,  nor  lymphocyte-conditioned medium, nor 
homogenates of stimulated lymphocytes was able to  induce monocyte PCA  (Table 
VI). 
Heat  Inactivation Studies for  LPS.  LPS  is  known to  cause  an  increase in  PCA  in 
human  PBM  (9).  To  exclude  LPS  contamination of  the  stimulatory  Ag:Ab  or 
aggregated IgG as a cause of PCA induction, comparative heat inactivation was done 
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denatured and the ability of the solution to induce PCA in PBM was destroyed in 
parallel. Whereas IgG is denatured and precipitated, LPS is not  (18). As such, LPS 
heated at 99°C for 30 min was just as stimulatory for PCA as was unheated LPS. By 
the same token, a solution of Ag:Ab complexes containing added LPS induced PCA. 
After heating, this solution retained the capacity to induce PCA production, indicating 
the heat stability of the added  LPS.  All preparations of Ag:Ab  or aggregated  IgG 
were heat labile for induction of PCA excluding LPS at the level of 2 ng/ml Ag:Ab 
or aggregated  IgG.  Freedom  from  LPS contamination  at  this  level  has  also  been 
confirmed by amebocyte lysate assay. 
Nature of the PCA.  PBM incubated with Ag:Ab complexes or aggregated IgG were 
assayed using plasmas from individuals congenitally deficient in a single coagulation 
factor. The PCA was fully active in Factor XII-deficient plasma (3,600 mU/106 cells), 
Factor VIII-deficient plasma  (3,200 mU/106 cells), and  Factor IX-deficient plasma 
(3,400  mU/106  cells).  However,  a  reduced  rate  of clotting  occurred  in  plasmas 
deficient in Factor VII (200 mU/106 cells), Factor X  (150 mU/10  n cells), or Factor II 
(120 mU/106). The observations are characteristic of tissue factor-induced coagulation 
via the extrinsic pathway. 
Discussion 
As  previously described  (11)  and  confirmed in  this study, human  PBM  contain 
very low basal  levels of PCA, which is increased severalfold by exposure to Ag:Ab 
complexes or aggregated IgG. This increase is observed whether one examines viable 
cells or disrupts cells to assess the total cellular content of PCA. 
The present study provides new and direct evidence that the monocyte is indeed 
the cell containing most if not virtually all of the basal PCA, and is the source of the 
PCA induced by incubation with Ag:Ab.  Edwards and Rickles (12)  have suggested 
the monocyte origin of cellular PCA using human monocyte-enriched fractions and 
LPS or phytohemagglutinin as stimuli. However, no rigorous proof has been presented 
that this is the case for the present system, that the monocyte per se is the responsible 
cell, or that cellular collaboration is required. The latter seemed unlikely because Ag: 
Ab  and  aggregated  IgG  are  known  to  stimulate  phagocytosis  and  certain  other 
functional characteristics of the activated monocyte or macrophage. Such stimulus- 
coupled responses have included release of lysosomal hydrolases (19) or enhancement 
of plasminogen  activator secretion  (20).  Using  both  cell  fractionation  and  direct 
cytologic assay, we have directly localized the PCA product to the monocyte after Ag: 
Ab or aggregated IgG induction. First, when Ag:Ab-stimulated PBM were separated 
into lymphocytes and monocytes, each population containing < 1-2% of the other by 
nonspecific esterase staining,  which  is a  reliable method of distinguishing  between 
these cells (21), the monocyte fraction contained 96% of the PCA. Second, direct and 
compelling evidence that monocytes are the source of PCA comes from the cytologic 
procoagulant assay. This allows direct visualization of cell type by esterase staining 
and  of PCA  by  the  presence  of pericellular  fibrin.  By  this  method  only  9%  of 
lymphocytelike cells were positive for fibrin as compared with 91% of the monocytes 
from stimulated PBM. It should be noted that before in vitro incubation of the cells 
there were virtually no PCA-positive viable monocytes, suggesting that  this activity 
may not be displayed by the cell in vivo. These observations establish that indeed the 
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the response rather than some minor co-isolated cell population.  It is notable that 
whereas  lymphocyte preparations  show no  increase in  PCA  following stimulation, 
cytologic assay did show an increased number of PCA-positive lymphocytelike cells 
after Ag:Ab stimulation. Evidence from these and other experiments suggests that the 
cytologic assay may be more sensitive to small amounts of PCA than the one-stage 
clotting  assay,  hence  the  discrepancy  might  reflect  the  production  of very small 
amounts of PCA by a few lymphocytes or possibly by monocyte precursors. 
The time-course for induction of cellular PCA is extremely rapid, reaching maximal 
levels within 6  h. This is in contrast  to some of the more commonly characterized 
functions  of  lymphoid  cells,  such  as  lectin-stimulated  DNA  synthesis  or  mixed 
lymphocyte reactions, which  require  several  days  to  attain  a  maximum  response. 
Similarly,  maximal  monocyte/macrophage production  of inflammatory mediators 
such  as  plasminogen  activator  (22)  and  collagenase  (23)  follows  a  much  more 
protracted time-course. Evidence for rapid expression of PCA in vivo can be found in 
lesions  such  as  experimental  allergic  encephalomyelitis,  where  perivaseular  fibrin 
deposition is one of the earliest histologically identifiable events (1). Whether there is 
correlation between a  very early event, such as PCA production, and  later cellular 
events is under investigation. 
The  present  study  indicates  that  monocytes require  unidirectional  lymphocyte 
collaboration in  order to manifest  an  immune  complex-induced increase in  PCA. 
Monocytes alone incubated with Ag:Ab or aggregated IgG do not show an increase. 
Platelets, although possessing Fc receptors (24, 25) and present in PBM populations, 
did not influence Ag:Ab-induced PCA production by monocytes, nor did they directly 
substitute for the lymphocyte requirement. Indeed, monocyte PCA was augmented 
only by incubation with lymphoeytes that had been exposed to Ag:Ab or aggregated 
IgG. The specificity of this stimulus to monocyte PCA is noted by the ability to titrate 
the amount  of PCA  produced by adding different proportions of Ag:Ab-triggered 
lymphocytes, and by the inability of Ag:Ab-incubated monocytes to induce PCA in 
other monocytes. Somewhat surprising was the inability of Ag:Ab- or aggregated IgG- 
incubated  monocytes  to  be  induced  by  the  subsequent  addition  of untriggered 
lymphocytes. Apparently, once the soluble immune complexes have interacted with 
the monocyte Fc receptor, they cannot subsequently interact with the lymphocyte so 
as to induce the required lymphocyte "help", or they have been eclipsed from the 
monocyte surface. 
These  data  provide  evidence that  the  cellular  interaction  required  for  Ag:Ab- 
augmented  PCA  production is  indeed  unidirectional  in  character:  lymphocyte 
monocyte. This observation contrasts with selected other macrophage responses such 
as  phagocytosis,  which  is  a  direct  response  to  relevant  stimuli  (26),  and  Listeria 
monocytogenes-induced macrophage-mediated triggering of lymphocytes. In the latter 
response, the lymphocyte responds by synthesizing and  releasing macrophage acti- 
vating  factor, hence forming a  circular pathway  (27,  28).  Furthermore, it  appears 
that intact lymphocytes were required for the collaborative production of monocyte 
PCA.  Neither culture supernates from Ag:Ab-incubated lymphocytes, nor lympho- 
cyte-conditioned medium,  nor  disrupted  lymphocytes were  able  to  substitute  for 
viable lymphocytes. This does not rule out the possibility that a soluble lymphocyte 
mediator is involved, because the presence of an extremely labile molecule cannot be 
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from phytohemagglutinin-stimulated  T lymphocyte-enriched (70%) populations could 
stimulate a  partial PCA response when added to monocyte-enriched cell fractions. 
However, monocytes obtained  by such  short  periods  of adherence contained  15% 
lymphocytes. Whether these lymphocytes had specifically adhered to the monocytes 
and were able to interact with phytohemagglutinin in the transferred medium and 
induce  PCA  production  in  monocytes is open  to  question.  Their  incubation with 
stimulus was 24 h, compared with 6 h in the present study. This may also contribute 
to the different findings because there is precedent for viable cells mediating events 
more  rapidly  than  soluble  products  (29).  However,  the  possibility should  not  be 
dismissed that lectins and Ag:Ab could use different pathways for the induction of 
lymphoid PCA. 
The response to Ag:Ab or aggregated IgG appears saturable in respect to the dose 
of immune complexes.  Moreover, increasing the direct stimulus to monocytes, i.e., 
increasing  the  number  of stimulated  lymphocytes,  produced  a  maximum  PCA 
response at 4:1 lymphocytes to monocytes. This indicates that the ultimate restriction 
as to magnitude of the response was at the level of the monocyte, not the amount of 
lymphocyte signal provided. 
The  PCA produced by monocytes after exposure to Ag:Ab- or aggregated IgG- 
triggered lymphocytes appeared to be of classical tissue factor type (30). Homogenates 
of stimulated cells accelerated the clotting of recalcified human plasma deficient in 
Factor XII, Factor VIII, Factor IX, but not plasma deficient in Factor VII, Factor X, 
or prothrombin, thus indicating the requirement for these latter factors. PCA was not 
detected in supernatant medium from monocyte cultures clarified by centrifugation, 
indicating that cellular assay is sufficient in evaluating this biological response. That 
this induction results from Ag:Ab or aggregated IgG and not contaminating LPS has 
been previously validated (11,  17) and was again demonstrated by heat inactivation. 
Monocyte participation in initiating thrombosis and fibrinolysis has been  impli- 
cated  before;  plasminogen  activator  is  produced  by  human  monocytes,  and  this 
response is augmented by the presence of lymphocytes (31). Furthermore, monocytes 
produce several enzymes that participate at various stages of the inflammationary 
reaction  (19,  22,  23).  At such  sites,  fibrin deposition is  frequently associated with 
immune complex-mediated tissue damage. Based on the present studies, we suggest 
that monocytes may generate the local PCA required for such local fibrin generation. 
For example, in experimental immune complex glomerulonephritis, circulating mon- 
ocyte localization in glomeruli is requisite (32, 33).  In addition, the activation of the 
coagulation  pathways  and  the  formation  of fibrin  may  also  be  required  in  the 
pathogenetic sequence (34, 35). It is of interest that the small soluble Ag:Ab complexes 
generate the greatest increment in PCA (11). Whereas small soluble complexes may 
be less phlogogenic than the larger complexes that deposit (36, 37), soluble complexes 
may possess previously unassessed pathogenetic properties, such as inducing the PCA 
pathway. 
It is tempting to speculate on the contribution of lymphoid PCA to phenotypic 
expression of immune complex disease. For instance, Clarkson et al. (38) have recently 
hypothesized that the increased rate of atherosclerosis among vasectomized men may 
be related to the immune complexes present in their serum. Similarly, in the immune 
complex disease of BxSB hybrid mice, coronary thrombosis and degenerative vascular 
disease is a prominent associated event (39). It may be necessary to consider whether 904  IMMUNE COMPLEX-INDUCED MONOCYTE PROCOAGULANT RESPONSE 
elaboration  of PCA  by monocytes in  response to  properly stimulated  lymphocytes 
could be a participatory pathway linking the immune system and coagulation process 
in these diseases. 
Summary 
It has previously been described that soluble antigen:antibody complexes in antigen 
excess can induce an increase in the procoagulant activity of human peripheral blood 
mononuclear cells. It has been proposed that this response may explain the presence 
of fibrin in immune complex-mediated tissue lesions. In the present study we define 
cellular participants and their roles in the procoagulant response to soluble immune 
complexes.  Monocytes were  shown  by cell  fractionation  and  by a  direct  cytologic 
assay to be the cell of origin of the procoagulant activity; and virtually all monocytes 
were able to participate in the response. Monocytes, however, required the presence 
of lymphocytes to respond. The procoagulant response required cell cooperation, and 
this  collaborative interaction  between  lymphocytes and  monocytes appeared  to  be 
unidirectional. Lymphocytes once triggered by immune complexes induced monocytes 
to synthesize the procoagulant product.  Intact viable lymphocytes were required  to 
present  instructions  to monocytes;  no soluble  mediator could  be found  to subserve 
this  function.  Indeed,  all that  appeared  necessary to  induce  monocytes to produce 
procoagulant activity was an encounter with lymphocytes that had previously been 
in  contact  with  soluble  immune  complexes.  The  optimum  cellular  ratio  for  this 
interaction  was four lymphocytes per monocyte, about  half the ratio in  peripheral 
blood. The procoagulant response was rapid, reaching a  maximum within 6 h  after 
exposure  to  antigen:antibody  complexes. The procoagulant  activity was  consistent 
with  tissue  factor because  Factors  VII and  X  and  prothrombin  were  required  for 
clotting of fibrinogen. We propose that this pathway differs from a  number of others 
involving cells of the immune system. Elucidation of the pathway may clarify the role 
of this  lymphocyte-instructed  monocyte response in  the  Shwartzman  phenomenon 
and other thrombohemorrhagic events associated with immune cell function and the 
formation of immune complexes. 
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